Recent Press Releases

For Parkinson's Disease Treatment, Surveyed Neurologists in France Use Once-Daily Formulations of Requip and Mirapex More Freque

Reimbursement for Parkinson's Disease Therapies is Generally Not Restricted in Any of the EU5 Countries, According to a New Report from Decision ResourcesBURLINGTON, Mass., Nov. 30, 2010 /PRNewswire/

AVANIR Pharmaceuticals Announces Fiscal 2010 Fourth Quarter and Full Year Financial Results

ALISO VIEJO, Calif., Nov. 30, 2010 /PRNewswire-FirstCall/ -- AVANIR Pharmaceuticals, Inc. (Nasdaq: AVNR) today reported unaudited financial results for the three and twelve months ended September 30,

Seattle Genetics Announces Additions to Commercial Leadership Team

BOTHELL, Wash.--(BUSINESS WIRE)-- Seattle Genetics, Inc. (Nasdaq: SGEN) today announced the appointment of Chris Boerner, Ph.D. as Vice President, Marketing and Darren Cline as Vice President,

Merck Board Elects Kenneth C. Frazier as Next CEO; Richard T. Clark to Continue as Chairman

Merck Board Elects Kenneth C. Frazier as Next CEO; Richard T. Clark to Continue as Chairman New Roles Effective January 1, 2011 WHITEHOUSE STATION, N.J., Nov. 30, 2010 - Merck (NYSE: MRK) today

BioDelivery Sciences Announces Resumption of ONSOLIS Manufacturing

RALEIGH, N.C., Nov 23, 2010 (BUSINESS WIRE) -- BioDelivery Sciences International, Inc. /quotes/comstock/15*!bdsi/quotes/nls/bdsi (BDSI 2.82, -0.04, -1.40%) today announced that manufacturing of

VisionCare Appoints Richard Powers Executive Vice President

Hiring of Industry Veteran Strengthens and Broadens Management TeamSARATOGA, Calif., Nov. 30, 2010 /PRNewswire/ -- VisionCare Ophthalmic Technologies, Inc., a developer of advanced visual prosthetic

Spectrum Pharmaceuticals Board Approves Replacement of Stockholder Rights Agreement

IRVINE, Calif.--(BUSINESS WIRE)-- Spectrum Pharmaceuticals, Inc. (NasdaqGM: SPPI) announced today that on November 29, 2010 its Board of Directors met with its legal and financial advisors to

Merck Board Elects Kenneth C. Frazier as Next CEO;Richard T. Clark to Continue as Chairman

New Roles Effective January 1, 2011 WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)-- Merck (NYSE: MRK) today announced that its Board of Directors has elected Kenneth C. Frazier, currently Merck’s

FDA and Life Sciences Industry Relationship is Complicated by New Science and Changing Expectations, Finds PwC Survey

NEW YORK, Nov. 30, 2010 /PRNewswire/ -- Growing public demand for increased medical device and drug safety, as well as the need to develop medical products faster, is complicating the current

Caltrate® Soft Chews Offer A New and Delicious Way to Help Americans Reach Their Recommended Daily Calcium and Vitamin D Intake

National Guidelines Issued Today Champion the Benefits of Calcium and Recommend Daily Increase for Vitamin DMADISON, N.J., Nov. 30, 2010 /PRNewswire/ -- On the heels of the Institute of Medicine

Lubiprostone Successfully Completes Long-Term Phase 3 Safety Trial in Japanese Patients with Chronic Idiopathic Constipati

BETHESDA, Md. & ABBOTT PARK, Ill.--(BUSINESS WIRE)-- Sucampo Pharmaceuticals, Inc. (NASDAQ: SCMP) and Abbott (NYSE:ABT) today announced positive top-line data from a 48-week phase 3 long-term

Impax Laboratories Confirms Patent Suit Relating to Generic Concerta® 54 mg Tablets

HAYWARD, Calif.--(BUSINESS WIRE)-- Impax Laboratories, Inc. (NASDAQ:IPXL) today confirms that Alza Corporation has filed suit for patent infringement against Impax in the United States District Court

Reportlinker Adds Colorectal and Colon Cancer Therapy Area Pipeline Report

NEW YORK, Nov. 29, 2010 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: Colorectal and Colon Cancer Therapy Area Pipeline Report

Government patent box proposals 'transform' UK attractiveness for investment

Government patent box proposals ‘transform' UK attractiveness for investment Issued: Monday 29th November 2010, London, UK GSK to invest £500m in manufacturing projects New £50m

Cardinal Health Acquires Leading Pharmaceutical Distributor in China

Cardinal Health Acquires Leading Pharmaceutical Distributor in China Acquisition establishes growth platform in China China expected to become world's second largest pharmaceutical market by 2015

BioMarin to Present at the Piper Jaffray Healthcare Conference

NOVATO, Calif., Nov. 29, 2010 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) today announced that Jeffrey Cooper, Chief Financial Officer of BioMarin, will present a company update at

Perrigo Announces Launch of Naproxen Sodium Soft Gels - Generic Equivalent to Aleve® Liquid Gels

Perrigo Announces Launch of Naproxen Sodium Soft Gels - Generic Equivalent to Aleve® Liquid Gels ALLEGAN, Mich., Nov. 29, 2010 /PRNewswire/ -- Perrigo (Nasdaq: PRGO; TASE) today announced that

Pfizer to Present Data from Its Hematology Portfolio at the 52nd Annual Meeting of the American Society of Hematology

Company to Present Phase 3 Data Studying Bosutinib in Chronic Myeloid LeukemiaNEW YORK, Nov. 29, 2010 /PRNewswire-FirstCall/ -- Pfizer (NYSE: PFE) said today that new data on investigational

SDI AND CEGEDIM STRATEGIC DATA ANNOUNCE ONCOLOGY PARTNERSHIP

SDI AND CEGEDIM STRATEGIC DATA ANNOUNCE ONCOLOGY PARTNERSHIPAgreement to Jointly Launch New Oncology Promotion Audit ServicePLYMOUTH MEETING, Pa. - Nov. 29, 2010 - SDI and Cegedim Strategic Data

3SBio Inc. Acquires Worldwide Rights to Pegsiticase From EnzymeRx

SHENYANG, China, Nov. 29, 2010 /PRNewswire-Asia-FirstCall/ -- 3SBio Inc. (Nasdaq: SSRX) ("3SBio" or "Company"), a leading China-based biotechnology company focused on researching, developing,